glp-1 generic FDA approves first liraglutide once-daily injection Consumer group presses U.S. to

Methods In accordance with the PRISMA guidelines, we systematically searched PubMed, Embase, Cochrane Library, Web of Science, Scopus, and LILACS for randomized controlled trials and observational studies published between 2000 and 2025

The GLP-1 receptor agonist market is experiencing significant growth, driven by the increasing prevalence of type 2 diabetes and obesity, and the high...

Immobilized Human GLP-1R, mFc Tag at 1 g/ml (100 l/well) on the plate

The science, promise and clinical development of GLP-1 and GIP receptor agonists in obesity

Alexandra Sowa discusses the surge in GLP-1 use, concerns over prescriptions without in-person visits and how ChatGPT health may help patients get faster treatment.

A one-year course of semaglutide partially reversed WR, suggesting a potential adjunctive role for GLP-1 agonists in selected patients